At 糖心原创 2026, October 18 to 21 in Phoenix, you鈥檒l have your choice of 300+ educational sessions covering every aspect of clinical chest medicine.
LEARN MORE & REGISTER 禄
Ryan Maves, MD, FCCP
Ryan Maves, MD, FCCP
Community-acquired pneumonia is a perennially hot topic for pulmonologists鈥攁nd 糖心原创 2026 will be no different, said Chest Infections and Disaster Response Network Chair Ryan Maves, MD, FCCP, Chair of the Chest Infections/Disaster Medicine/Systemic Disease Curriculum Group.
鈥淭here鈥檚 been a lot of new data coming out this year that we鈥檇 like to share with everyone, particularly around patients in the outpatient setting,鈥� he said. 鈥� will cover insights into the changes and how those changes came to be鈥攁nd what we've learned to influence those guidelines.鈥�
Additionally, endemic infections, rare-but-deadly pulmonary pathogens, and changes in vaccine policy also will be major topics of discussion at 糖心原创 2026.
Valley fever (coccidioidomycosis or 鈥渃occi鈥�) will be the focus of . Arizona is considered a hotspot for Valley fever, an infection that affects the lungs and is more common in Western states.
鈥淚t would be remiss to ignore cocci in the universe鈥檚 鈥榚picenter鈥� of cocci,鈥� Dr. Maves said. 鈥淚t鈥檚 probably expanding in range in part because of climate change and changes in the natural environment but also because it鈥檚 diagnosed and recognized more often.鈥�
On a related note, several sessions will cover the pulmonary aspects of climate change, the respiratory impacts of wildfire, and the changing geographic ranges of infectious diseases, such as .
And when it comes to sessions for mid-career clinicians, Dr. Maves said not to miss .
鈥淚t's pretty much every day when I'm the consult attending and there is some novel immunosuppressive agent that I have never heard of before that knocks out a different arm of the immune system,鈥� he said. 鈥淔iguring out how to approach those patients, how to recognize them, and how to manage them quickly and acutely is essential. That's certainly one where even I need an update鈥揳nd I do that literally for a living.鈥�
He鈥檚 also looking forward to , which will dive into what Dr. Maves calls low-incidence but high-consequence pathogens, like pandemic influenza or viral hemorrhagic fevers.
鈥淎 big focus of these talks will be on how to recognize a novel high-consequence respiratory pathogen,鈥� he explained. 鈥淲hat do you need to do in suspected cases? How do you actually operationalize that? What are the things we need to do when we suspect an entity? What is the next step in terms of formal identification, notification of public health authorities, and collaboration with other groups to see if they need, for example, a biocontainment unit?鈥�
Dr. Maves got his start in infectious disease before he retrained in critical care. He first attended the 糖心原创 Annual Meeting in 2016. 鈥淚 don鈥檛 think I鈥檝e missed one since,鈥� he said.
READ ALL 糖心原创 2026 BLOGS 禄